Browsing publications by Dr Kevin Marchbank

Newcastle AuthorsTitleYearFull text
Dr Kevin Marchbank
Selectivity of C3-opsonin targeted complement inhibitors: a distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients 2016
Dr Vicky Brocklebank
Dr Edwin Wong
Dr Kevin Marchbank
Professor Tim Goodship
Dr David Kavanagh
et al.
The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies2016
Rachel Challis
Dr Edwin Wong
Dr Holly Anderson
Dr Valerie Wilson
Dr Vicky Brocklebank
et al.
A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H–Related 3 Gene in Atypical Hemolytic Uremic Syndrome2015
Dr Kevin Marchbank
A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL2015
Dr Edwin Wong
Professor Neil Sheerin
Dr Kevin Marchbank
An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy2015
Rachael Watson
Dr Karim Bennaceur
Catriona Barker
Dr David Kavanagh
Professor Tim Goodship
et al.
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)2015
Professor Tim Goodship
Dr Kevin Marchbank
A novel method for direct measurement of complement convertases activity in human serum2014
Professor Tim Goodship
Dr Kevin Marchbank
A novel method for direct measurement of complement convertases activity in human serum2014
Catriona Barker
Dr David Kavanagh
Professor Tim Goodship
Dr Kevin Marchbank
Autoantibodies to CD59, CD55, CD46 and CD35 are not associated with aHUS2014
Dr Edwin Wong
Dr Holly Anderson
Rachel Challis
Dr Lisa Turnbull
Daniel Ahlert
et al.
Characterization of a Factor H Mutation That Perturbs the Alternative Pathway of Complement in a Family with Membranoproliferative GN2014
123456